Prevention of atrial fibrillation with SGLT2 inhibitors across the spectrum of cardiovascular disorders: a meta-analysis of randomised controlled trials
Fedele D, Casuso Alvarez M, Maida A, et al.
Eur Heart J Cardiovasc Pharmacother. 2025:pvaf040.
Leggi